Mitochondrial Dysfunction in Aging, HIV, and Long COVID: Mechanisms and Therapeutic Opportunities

Area of Science:

• Mitochondrial biology
• Aging research
• Infectious diseases
• Post-viral syndromes

Background:

• Mitochondrial dysfunction is a common pathway in aging, HIV, and long COVID.
• Independent treatment approaches may overlook shared pathogenic mechanisms.

Purpose of the Study:

• To explore a unified mitochondrial perspective on aging, HIV, and long COVID.
• To identify shared mechanisms and therapeutic vulnerabilities.
• To review emerging organelle-based therapies.

Main Methods:

• Literature review of current evidence on mitochondrial changes.
• Examination of shared mechanisms: oxidative stress, mitophagy, mtDNA damage, metabolic reprogramming.
• Analysis of emerging therapeutic strategies: mitochondrial transfer, transplantation, mtDNA correction.

Main Results:

• Mitochondrial dysfunction drives energy failure and chronic inflammation in aging, HIV, and long COVID.
• Shared mechanisms include oxidative stress, impaired mitophagy, mtDNA damage, and metabolic reprogramming.
• New therapies like mitochondrial transfer show preclinical and clinical proof-of-concept.

Conclusions:

• A unified mitochondrial perspective highlights interconnectedness between aging, HIV, and long COVID.
• Organelle-based therapies present promising, yet challenging, future treatment options.
• Further research is needed on safety, durability, and translation of these novel therapies.